国际标准期刊号: 2161-119X

耳鼻喉科:开放获取

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • ICMJE
分享此页面

抽象的

Oral Care for Mouth Sores

Alisa Joy Cooper*

Cancer treatments and radiation therapy can result in medically-induced oral mucositis (OM) which presents challenges for medical professionals of otolaryngology. Nearly 40% of patients undergoing cancer treatment experience OM, manifesting as mouth sores that may increase in severity and discomfort to compromise the quality or even jeopardize a patient’s life. Oral mucositis often leads to hospitalizations to address secondary infections or administer analgesic medications. While medications are available to treat the symptoms and complications of oral mucositis, many of these have side effects and none are able to prevent the condition from developing. As a result, the management of oral mucositis centers around a comprehensive oral hygiene regimen that includes the use of oral rinses. Several of the mouth rinses popular among cancer patients have their own side effects or limitations. One mouth rinse growing in use and popularity among cancer patients contains stabilized chlorine dioxide (SCD) and has shown no adverse side effects. This article presents the results of patient interviews conducted to determine the effectiveness of SCD products in alleviating medically-induced oral mucositis. Included are 5 case histories that reflect positive, yet diverse, experiences of cancer patients using SCD oral health products during, and after, their cancer treatments. Doctors and support staff working in the field of otolaryngology can become acquainted with the challenges of oral mucositis and offer care, education and emotional support to ease the unique burden of this segment of their patient population.